BioRelix's Series B - II Round

BioRelix raised a round of funding on January 11, 2012. Investors include Connecticut Innovations.

BioRelix is discovering and developing new treatments for infectious diseases that target RiboSwitches, a class of RNA drug targets found in pathogenic bacteria and fungi. Riboswitches are short stret…

Articles about BioRelix's Series B - II Round: